We would like to take this opportunity to once again express our sincere condolences the family and friends of Mr Harris.
The Health Board fully accepts the recommendations of the Ombudsman and would like to take this opportunity to apologise to his partner publicly for our failings.
The safety and quality of care of all our patients is very important and the consent process is a crucial part of this. Although these tragic events involve one individual patient and one clinical team we recognise that it is something we can all learn from.
– Spokesperson for Abertawe Bro Morgannwg University Health Board
A drug designed to combat Tuberous Sclerosis is being trialled at Cardiff University and could also be used to treat autism. Everolimus has already proven effective when used to treat kidney growths and grain tumours - reducing their size in many cases.
Tuberous Sclerosis is a genetic disorder characterised by the development of tumours in many organs, including the skin and kidneys. It can also affect the brain, leading to epilepsy and often ADHD and autism.